Safety and Effectiveness of Autologous Adipose Tissue Derived Mesenchymal Stem Cell Implantation in Patients With CP

Safety and Effectiveness of Autologous Adipose Tissue Derived Mesenchymal Stem Cell Implantation in Patients With Cerebral Palsy (CP)

Safety and Effectiveness of Autologous Adipose Tissue Derived mesenchymal Stem Cell Implantation in Patients with CP

The purpose of this study is to investigate the efficacy and safety of autologous transplantation of Adipose Tissue derived Mesenchymal stem cells (MSCs) in patient with Cerebral Palsy(CP)

Inclusion Criteria:

• Children with spastic cerebral palsy of spastic paraplegia or quadriplegia involving the two side occurred at birth or before birth
• Age : 36 months - 12 year, males and females
• Subjects who understand and sign the consent form for this study
• Kaufman Assessment Battery for Children 50<K-ABC<100

Exclusion Criteria:

• The last three months had seizures or epilepsy patients taking the durg
• Genetic Diseases
• Recent cancer patients within 1 year
• patients witn a psychiatric disorder that may interfere in the clinical trial
• participating another clinical trials within 3 months
• Recently there is a change of the abrupt symptoms within three months of the patient
• Subjects with a infectious disease include HIV and VDRL
• Patients who penicillin hypersensitivity reactions
• Other pathologic conditions or circumstances that difficult participation in the study according to medical criteria